SCHEMBL17685741

SCHEMBL17685741

O=C(O)CCCCCCCC=CCC=CCCCCCCCOc1cc(CO)cc(OCCCCCCCC=CCC=CCCCCCCCC(=O)O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.50
▸ PPARG P37231 7/20 0.50
▸ F7 P08709 6/20 0.50
▸ F3 P13726 6/20 0.50
▸ PPARD Q03181 6/20 0.50
▸ PPARA Q07869 6/20 0.50
▸ FFAR1 O14842 5/20 0.50
▸ CYP19A1 P11511 4/20 0.50
▸ MAPT P10636 4/20 0.50
▸ LMNA P02545 4/20 0.50
▸ ALOX15 P16050 4/20 0.50
▸ HSD17B10 Q99714 4/20 0.50
▸ PTGS1 P23219 3/20 0.50
▸ KDM4E B2RXH2 3/20 0.50
▸ CYP3A4 P08684 3/20 0.50
▸ HPGD P15428 3/20 0.50
▸ TDP1 Q9NUW8 3/20 0.50
▸ L3MBTL1 Q9Y468 3/20 0.50
▸ RECQL P46063 3/20 0.50
▸ BLM P54132 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30849137 0.85 ALDH1A1 (0.49) ALDH1A1PPARGF7F3PPARD
SCHEMBL30284571 0.85 ALDH1A1 (0.49) ALDH1A1PPARGF7F3PPARD
SCHEMBL17685809 0.85 ALDH1A1 (0.49) ALDH1A1PPARGF7F3PPARD
SCHEMBL17685831 0.85 ALDH1A1 (0.49) ALDH1A1PPARGF7F3PPARD
SCHEMBL17685803 0.85 ALDH1A1 (0.49) ALDH1A1PPARGF7F3PPARD
SCHEMBL25431443 0.85 ALDH1A1 (0.49) ALDH1A1PPARGF7F3PPARD
SCHEMBL17685786 0.85 ALDH1A1 (0.49) ALDH1A1PPARGF7F3PPARD
SCHEMBL17685788 0.85 ALDH1A1 (0.49) ALDH1A1PPARGF7F3PPARD
SCHEMBL17685710 0.85 ALDH1A1 (0.49) ALDH1A1PPARGF7F3PPARD
SCHEMBL30284624 0.85 ALDH1A1 (0.49) ALDH1A1PPARGF7F3PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964608-B1 LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS NOVARTIS AG (CH) 2019-08-28 — — EP disclosed
US-10124065-B2 Lipids and lipid compositions for the delivery of active agents NOVARTIS AG (CH) 2018-11-13 — — US disclosed
US-20160106842-A1 LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC. 2016-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10124065-B2 Lipids and lipid compositions for the delivery of active agents LIPA, LPAR1, LPAR4 ALDH1A1 2488/4885PPARG 1398/4885F7 626/4885
US-20160106842-A1 LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS LIPA, LPAR1, LPAR4 ALDH1A1 2488/4885PPARG 1398/4885F7 626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback